News Search Results
Jun 01, 2026, 08:00 ET Wockhardt Receives U.S. FDA Approval for ZAYNICH™ (cefepime and zidebactam), a Novel Intravenous Antibiotic for the Treatment of Adult Patients with Complicated Urinary Tract Infection Including Pyelonephritis
full Prescribing Information for ZAYNICH™.About WockhardtWockhardt is a global pharmaceutical and biotechnology company focused on developing innovative anti-infective solutions. With a legacy of scientific excellence and a mission to combat antimicrobial
More news about: Wockhardt
Jun 01, 2026, 07:00 ET Biond Biologics and Guangzhou-Israel Biotechnology Fund ("GIBF") Announce Closing of $8 Million Investment and Collaboration
www.biondbio.comAbout GIBF (Guangzhou-Israel Biotechnology Fund)The Guangzhou-Israel Biotechnology Fund (GIBF) is a specialized life science investment fund focused on advancing innovative biotechnology companies and technologies through strategic investment and development
More news about: Biond Biologics Ltd.; GIBF
Jun 01, 2026, 07:00 ET Decoy Therapeutics Partners with hVIVO to Advance Lead D-MAV™ Candidate into the Clinic
CAMBRIDGE, Mass., June 1, 2026 /PRNewswire/ -- Decoy Therapeutics Inc. (Nasdaq: DCOY), a pre-clinical-stage biotechnology company pioneering a new category of antivirals, today announced the execution of a strategic development initiative designed to support the advancement
More news about: Decoy Therapeutics, Inc
Jun 01, 2026, 06:30 ET Skyhawk Therapeutics Announces Twelve-Month Interim Results from Phase 1/2 Clinical Trial of SKY-0515 in Huntington's Disease
rapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate RNA targets, today announced results from the twelve-month interim analysis
More news about: Skyhawk Therapeutics
Jun 01, 2026, 06:30 ET Skyhawk Therapeutics Announces Twelve-Month Interim Results from Phase 1/2 Clinical Trial of SKY-0515 in Huntington's Disease
rapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate RNA targets, today announced results from the twelve-month interim analysis
More news about: Skyhawk Therapeutics
Jun 01, 2026, 04:21 ET Kimera Labs Implements ISO 9001:2015, ISO 13485:2016, and ISO 22716:2007 Across Its Miramar Manufacturing Facility
MIRAMAR, Fla., June 1, 2026 /PRNewswire/ -- Kimera Labs, Inc., a clinical-stage biotechnology company specializing in the research and manufacture of placental mesenchymal stem cell-derived exosomes, today announced the integration of three
More news about: Kimera Labs Inc
Jun 01, 2026, 04:00 ET ZIM Board of Directors Appoints Dr. Chen Lichtenstein as President and CEO of the Company; will also be joining its Board of Directors
Directors at Teva Pharmaceuticals Ltd., as chairman of the board of directors at international companies in the fields of environmental sciences and biotechnology and as a senior advisor to international investment entities. Dr. Lichtenstein holds joint doctoral degrees from the Graduate School of Business
More news about: ZIM Integrated Shipping Services Ltd.
Jun 01, 2026, 03:00 ET LUCENT Appoints Simon Doyle as CEO with Matthew Goodman Taking Chief Medical Officer Position
remaining a core member of the leadership team at LUCENT. LUCENT was founded in 2022 by Goodman, providing specialist Medical Affairs support to biotechnology and pharmaceutical companies across the US, UK and Europe. As LUCENT enters its next phase of growth, this leadership change will ensure the continued
More news about: LUCENT Biopharma Ltd
May 31, 2026, 23:51 ET Aphranel® MagiCCrystal CaHA Filler obtient la certification MDR de l'UE en tant qu'injectable régénérateur de première qualité
SHANGHAI, 1er juin 2026 /PRNewswire/ -- Moyom Biotechnology a annoncé que son produit haut de gamme dédié à l'esthétique régénérative, Aphranel® MagiCCrystal CaHA Filler, a officiellement obtenu la certification au titre du règlement de l'Union européenne sur
More news about: SHANGHAI MOYOM BIOTECHNOLOGY CO., LTD; Aphranel
May 31, 2026, 23:50 ET Aphranel® MagiCCrystal CaHA Filler erhält die EU MDR-Zertifizierung als hochwertiges regeneratives Injektionsmittel
SHANGHAI, 1. Juni 2026 /PRNewswire/ -- Moyom Biotechnology gab bekannt, dass sein hochwertiges Produkt für regenerative Ästhetik, Aphranel® MagiCCrystal CaHA Filler, am 18. Mai 2026 offiziell die Zertifizierung nach der Medizinprodukteverordnung der Europäischen
More news about: SHANGHAI MOYOM BIOTECHNOLOGY CO., LTD; Aphranel
May 31, 2026, 22:37 ET ASCO 2026 | Oricell's GPC3 CAR-T Ori-C101 Hits 66.7% ORR in Late-Line HCC, Signaling Best-in-Class Potential
reach of our technology and deliver hope to patients worldwide."About Oricell TherapeuticsOricell is a clinical-stage global biotechnology company dedicated to becoming a pioneer in tumor immunotherapy. Focused on solving unmet medical needs in oncology and immunology, by powering a
More news about: Oricell Therapeutics Holdings Limited
May 31, 2026, 20:00 ET D3 Bio Presents First-Line Data for Elisrasib (D3S-001) at ASCO 2026; Next-Generation KRAS G12C Inhibitor Shows Landmark Efficacy in Untreated NSCLC
SHANGHAI, May 31, 2026 /PRNewswire/ -- D3 Bio Inc., a global clinical-stage biotechnology company dedicated to developing innovative oncology therapeutics, announced first-line (1L) clinical data of elisrasib
More news about: D3 Bio
May 31, 2026, 20:00 ET ImmVira Reports 100% Complete Response Rate at 9 Months in Bladder Carcinoma in Situ with MVR-T3011 at ASCO
administration including intratumoral, intracavitary and intravenous administrations.About ImmViraImmVira is a clinical-stage biotechnology company that is powered by proprietary biological engineering technology, and is dedicated to the discovery, development, manufacture and commercialization
More news about: ImmVira Group
May 31, 2026, 08:01 ET Lilly's Retevmo (selpercatinib) demonstrated an 83% reduction in the risk of disease recurrence or death as adjuvant therapy for people with early-stage RET fusion-positive lung cancer
pioneering life-changing discoveries for 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
May 30, 2026, 06:36 ET Chandigarh University Research Scientist Receives Startup Research Grant of Rs 24 Lakhs
Giving fillip to the cutting-edge research in crop biotechnology and sustainable agriculture, the research faculty and students at Chandigarh University's University Centre for Research & Development (UCRD) and University Institute of Biotechnology (UIBT) are making significant contributions in the
More news about: Chandigarh University
May 29, 2026, 16:01 ET AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE
best of biology and technology, Amgen reaches millions of patients with its medicines.More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge of innovation, using technology and human genetic
More news about: Amgen
May 29, 2026, 12:28 ET Lupin Receives Approval from U.S. FDA for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets
products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position
More news about: Lupin Pharmaceuticals, Inc.
May 29, 2026, 11:00 ET Colorectal Cancer Alliance and GCAR Announce Collaboration to Advance a Groundbreaking Adaptive Clinical Trial Platform for Colorectal Cancer: KLEOS
Society of Clinical Oncology Annual Meeting to advance the vision of the KLEOS adaptive clinical trial platform.Pharmaceutical and biotechnology partners are invited to connect with GCAR and the Colorectal Cancer Alliance at the American Society of Clinical Oncology Annual Meeting
More news about: Global Coalition for Adaptive Research
May 29, 2026, 10:45 ET Kalohexis Announces Publication in Nature Communications Highlighting Dual MC3R/MC4R Activation as a Novel, Durable Mechanism that Drives Weight Loss
NORTHBROOK, Ill., May 29, 2026 /PRNewswire/ -- Kalohexis, a clinical-stage biotechnology company harnessing the melanocortin system to shape the next era of metabolic disease care starting with obesity and cancer cachexia, today announced
More news about: Kalohexis
May 29, 2026, 08:00 ET SK bioscience Board Approves Financing Plan Supported by Korea Growth Fund
investment.The Korea Growth Fund is a public-private policy financing initiative established to foster strategic industries such as AI, semiconductors, biotechnology, and secondary batteries. Structured as a citizen-participation investment fund, it aims to provide long-term capital to future growth industries.
More news about: SK bioscience
May 29, 2026, 07:00 ET Alaw Therapeutics Announces Two Major Pipeline Milestones Advancing Brain-Penetrant CDK Oncology Programs
SAN DIEGO, May 29, 2026 /PRNewswire/ -- Alaw Therapeutics, Inc. ("Alaw"), a clinical-stage biotechnology company developing precision oncology therapeutics designed to control oncogenic proliferation, tumor survival, and therapeutic resistance, today
More news about: Alaw Therapeutics
May 29, 2026, 06:00 ET Harbinger Health Presents Clinical Data at ASCO Supporting RESOLVE™ as a New Blood-Based Category for Evaluation of Suspected Cancer
Harbinger Health, a biotechnology company pioneering cancer resolution, today announced the presentation of clinical data on Harbinger's multi-cancer detection test in symptomatic
More news about: Harbinger Health
May 29, 2026, 02:28 ET Aphranel® MagiCCrystal obtiene la certificación EU MDR
calidadSHANGHÁI, 29 de mayo de 2026 /PRNewswire/ -- Moyom Biotechnology dio a conocer hoy que su producto prémium de estética regenerativa, Aphranel® MagiCCrystal CaHA Filler, ha conseguido oficialmente la certificación
More news about: SHANGHAI MOYOM BIOTECHNOLOGY CO., LTD; Aphranel
May 28, 2026, 18:09 ET Kodiak Sciences to Present at 2026 Jefferies Global Healthcare Conference
Calif., May 28, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina-focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, today announced that Victor Perlroth, M.D., Chief
More news about: Kodiak Sciences Inc.
May 28, 2026, 13:00 ET Lilly to present new data on Foundayo, Mounjaro and retatrutide at the American Diabetes Association's 86th Scientific Sessions, building toward a new era of choice in diabetes and obesity care
pioneering life-changing discoveries for 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company